Randomized, Placebo-controlled Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients.
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record (Parent trial; NCT01258712 ).
- 10 Apr 2012 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov record (Parent trial; NCT01258712 ).
- 03 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.